CD274 and melanoma: Furthermore, we also found some therapeutic efficacy of BNT162b2-based cancer therapy in the advanced melanoma model, and this therapeutic efficacy can be further enhanced by combining anti-PD-L1 therapy as well (Supplementary Fig. S8a–c).